Population pharmacokinetics modelling for clinical dose adjustment of carboplatin in dogs
Abstract Background Carboplatin is a human chemotherapeutic agent which is frequently used in dogs for the management of solid tumors. In human patient, its dosage is adjusted carefully, based on the creatinine clearance computation. In dogs however, the pharmacokinetics of carboplatin is poorly kno...
Saved in:
| Main Authors: | Jérémy Béguin, Sarra Mahfoudhi, Marie Uzel, Antoine Rostang, Catherine Ibish, Aude A. Ferran, Ludovic Pelligand, Anne Hulin, Matthias Kohlhauer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Veterinary Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12917-024-04404-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer
by: Shu Kato, et al.
Published: (2025-04-01) -
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
by: Avinash Pandey, et al.
Published: (2014-01-01) -
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2025-03-01) -
L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
by: Seoeun Oh, et al.
Published: (2024-12-01) -
The treatment of stage A testicular seminoma by carboplatin monochemotherapy
by: Bojanić Nebojša, et al.
Published: (2009-01-01)